Amneal Lines Up Launches As It Builds Out Biosimilars Business
Generics Sales Remain Flat In Q3, But Alymsys Bevacizumab Biosimilar Makes Solid Start
• By David Wallace
Amneal is lining up multiple imminent biosimilar and generic launches • Source: Shutterstock 
